INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 28 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $318,000 | -12.6% | 42,236 | -34.4% | 0.39% | +14.9% |
Q3 2018 | $364,000 | +27.7% | 64,396 | -0.6% | 0.34% | +232.7% |
Q2 2018 | $285,000 | -27.8% | 64,817 | +0.8% | 0.10% | -76.5% |
Q1 2018 | $395,000 | +5.3% | 64,280 | -11.7% | 0.43% | -5.9% |
Q4 2017 | $375,000 | -44.9% | 72,782 | -4.4% | 0.46% | -34.2% |
Q3 2017 | $681,000 | – | 76,139 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
UBS Group AG | 1,296 | $7,000 | 0.00% |